• Dlin-MC3-DMA: Molecular Design and Translational Impact i...

  2025-09-29

  Explore the unique molecular design and translational applications of Dlin-MC3-DMA, an advanced ionizable cationic liposome enabling potent lipid nanoparticle siRNA and mRNA delivery. This article delivers new scientific insights into endosomal escape, hepatic gene silencing, and predictive formulation strategies.

• BGJ398 (NVP-BGJ398): Precision FGFR Inhibition in Cancer ...

  2025-09-28

  Discover how BGJ398 (NVP-BGJ398), a selective FGFR inhibitor, is revolutionizing oncology research through unparalleled specificity and mechanistic insight into FGFR-driven malignancies. This article uniquely explores translational applications, advanced signal pathway targeting, and future research potential.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Beyond NHE1 Inh...

  2025-09-27

  Explore how 5-(N,N-dimethyl)-Amiloride hydrochloride advances cardiovascular disease and endothelial injury research as a precise NHE1 inhibitor. This article uniquely examines its mechanistic depth and translational significance, including its role in intracellular pH regulation and emerging applications in vascular pathology.

• MG-132 in Precision Neuroproteostasis: Beyond Apoptosis A...

  2025-09-26

  Explore how MG-132, a potent proteasome inhibitor peptide aldehyde, enables advanced interrogation of neuroproteostasis, autophagy, and disease-relevant protein degradation. This article uniquely connects MG-132 research to NMDA receptor quality control and targeted intervention in neurological disease models.

• Sulfo-Cy7 NHS Ester: Pioneering Near-Infrared Dye for Tra...

  2025-09-25

  Discover how Sulfo-Cy7 NHS Ester, a sulfonated near-infrared fluorescent dye, is transforming translational bioimaging in placental and microbial vesicle research. This in-depth analysis explores unique mechanistic insights and experimental strategies for leveraging this dye in emerging disease models.

• EZ Cap™ Firefly Luciferase mRNA: Transforming DC-Targeted...

  2025-09-24

  Discover how EZ Cap™ Firefly Luciferase mRNA (5-moUTP) advances dendritic cell-targeted mRNA delivery and bioluminescent immunoassays. This article uniquely explores its role in next-generation vaccine platforms and immune activation studies.

• Tamoxifen: Mechanistic Versatility in Advanced Molecular ...

  2025-09-23

  Tamoxifen, a selective estrogen receptor modulator, is pivotal in molecular biology for its multifaceted roles from CreER-mediated gene knockout to kinase inhibition and antiviral investigations. This article critically examines novel mechanistic insights and practical applications of Tamoxifen, highlighting its utility beyond classical breast cancer research.

• In this study we designed and

  2025-03-03

  

  In this study, we designed and synthesized two ALK PROTACs (degraders), 5 (MS4077) and 6 (MS4078), by linking ceritinib and pomalidomide [45] through two different linkers. Using human ALCL and NSCLC cells, we characterized both compounds in a battery of assays to demonstrate their effects on reduci

• In terms of the full length

  2025-03-03

  

  In terms of the full-length proteins, it was noted early on that ACs have two cellular localizations: as integral proteins of the plasma membrane and as soluble proteins in the cytosol. Based on the distribution in mammalian sequences, it was initially proposed that subclass IIIa contains only membr

• The pathogenesis of d penicillamine

  2025-03-03

  

  The pathogenesis of d-penicillamine-induced MG is not clear. The repertoire of anti-AChR EZ Cap™ EPO mRNA in d-penicillamine-induced MG has been shown to be similar to that in idiopathic MG in terms of AChR antigenic regions, suggesting a common immune mechanism (Tzartos et al., 1988). About 20% o

• Osteoblasts have been thought to be the major cell

  2025-03-03

  

  Osteoblasts have been thought to be the major cell type that expresses RANKL (Suda et al., 1999) which is a ligand for osteoprotegerin (OPG) and which functions as a key factor for osteoclast differentiation and activation. Recently, Nakashima and his colleagues (Nakashima et al., 2011) demonstrated

• br Trauma and ACEs screening the past present and future

  2025-03-03

  

  Trauma and ACEs screening: the past, present, and future Traditionally, allopathy’s biomedical model has utilized an etic perspective; the outsiders’ view of the problem. Development of diagnostic screening tools requires an etic approach, which relies heavily on a completely objective perspectiv

• Anti LT therapy by LO inhibition has been hampered by

  2025-03-03

  

  Anti-LT therapy by 5-LO inhibition has been hampered by occurring liver toxicities by Zileuton or the clinical phase II compound Atreleuton [36], [37] However both compounds possess a thiophene as well as an N-hydroxyurea moiety. These features could be linked with reactive thiophene intermediates

• br Acknowledgments br Introduction Cancer

  2025-03-03

  

  Acknowledgments Introduction Cancer is the leading cause of mortality in the United States for those between the ages of 40–79 years, surpassing heart diseases by more than 100,000 deaths [1]. The cause of most cancer subtypes remains idiopathic and may arise out of ‘bad luck’ among otherwise

• br Autophagy and cell death pathways in ischemic

  2025-03-03

  

  Autophagy and cell death pathways in ischemic stroke Although very important for the effects on post-ischemic o-Phenanthroline receptor injury, autophagy is not the only mechanism of action involved in cell death. Necrosis and apoptosis are two other distinct forms of cell death with great diffe

16208 records 12/1081 page Previous Next First page 上5页 1112131415 下5页 Last page